Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
NIN
REST API REST API
Homo sapiens
NIN is differentially expressed in 213 experiments: 93 organism parts: tonsil, accumbens, ... (91 more);, 104 disease states: normal, breast carcinoma, ... (102 more);, 87 cell types 337 cell lines 32 compound treatments and 56 other conditions.
Orthologs NIN (Gallus gallus)   nin (Danio rerio)   NIN (Bos taurus)   Nin (Rattus norvegicus)   Nin (Mus musculus)   USO1 (Saccharomyces cerevisiae)   Gmap (Drosophila melanogaster)   nin (Xenopus laevis)   NIN (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, cytoskeleton, cytoplasm, centriole, GTP binding, centrosome, microtubule, nucleotide binding, calcium ion binding, centrosome localization, microtubule anchoring at centrosome, centrosome-templated microtubule nucleation
InterPro Term EF_HAND_2
UniProt Accession C9J066, Q8N4C6, Q5BKU3, E9PN67, E9PJH9, F8W6D3
Search EB-eye ENSG00000100503
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-GEOD-803, E-GEOD-6573, E-GEOD-6919, E-TABM-130, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-19639, E-GEOD-4219, E-GEOD-3202, E-GEOD-19466, ... (27 experiments)

Factor Value U/D Experiments
AGS
2
E-MTAB-37, E-GEOD-15460
DU145
2
E-GEOD-17482, E-GEOD-20089
K562
2
E-MTAB-37, E-GEOD-24147
LNCaP
2
E-GEOD-14464, E-GEOD-14990
MCF-7
2
E-GEOD-20081, E-GEOD-19639
SNU16
2
E-MTAB-37, E-GEOD-15460
331 more value(s).


Cell type

studied in E-GEOD-22529, E-GEOD-20193, E-GEOD-4219, E-GEOD-20677, E-GEOD-13909, ... (37 experiments)

Factor Value U/D Experiments
human embryonic stem cell
2
E-GEOD-18265, E-GEOD-20033
induced pluripotent stem cell
2
E-GEOD-18147, E-GEOD-18265
B-cell
1
1
E-GEOD-10820
iPS cells from episomal vectors (Defined Factor sub-clone)
1
E-GEOD-20033
naive T cell
1
E-GEOD-1460
mature monocyte derived dendritic cell
1
E-GEOD-4984
81 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-22529, E-MEXP-882, E-MEXP-2069, ... (47 experiments)

Factor Value U/D Experiments
control
3
E-GEOD-21912, E-GEOD-16363, E-GEOD-8121
adrenocortical carcinoma
2
E-GEOD-10927, E-TABM-311
benign prostatic hyperplasia
2
E-MEXP-2034, E-MEXP-1243
no atrial fibrillation
1
E-GEOD-2240
oligodendroglioma
1
E-GEOD-4290
uterine fibroid
1
E-GEOD-7307
98 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-15205, E-TABM-782, E-TABM-868, E-GEOD-5099, ... (19 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
none
4
5
E-MEXP-1958, E-MEXP-1601, E-GEOD-20719, E-TABM-782, E-TABM-868, ... (9 experiments)
AMP
1
1
E-MEXP-2285
ZMYM2/FGFR1
1
E-GEOD-15811
sevoflurane
1
E-GEOD-4386
TTA
1
E-MEXP-2590
26 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-22513, E-GEOD-4619, E-GEOD-20499, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-5999, E-GEOD-20033, E-GEOD-4667

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-GEOD-22148, E-MEXP-2280, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MEXP-1482, E-GEOD-7578, E-GEOD-20847, ... (7 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-TABM-868, E-TABM-601, E-MEXP-1838, ... (8 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-MEXP-2657, E-GEOD-12773, E-TABM-127, E-GEOD-20504, E-GEOD-19018, ... (8 experiments)

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

immunoprecipitated protein
studied in E-GEOD-21918

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-176, E-MEXP-1290, E-MEXP-2069, ... (24 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-19703, E-GEOD-1657, E-GEOD-1460, E-GEOD-17636, E-GEOD-4600 ... (5 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-2115, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-19743, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-12198 ... (5 experiments)

Tumor grading
studied in E-GEOD-4290, E-GEOD-22541

Processing time: 0.329 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM